ERJ open research · 2025
Airflow obstruction among young adults in Europe: a Chronic Airway Diseases Early Stratification (CADSET) collaboration with 48 612 individuals across eight population-based cohorts.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Çolak Yunus, Allinson James P, van den Berge Maarten, Jarvis Debbie, Langhammer Arnulf, Breyer-Kohansal Robab, Nwaru Bright I, Backman Helena, Vonk Judith M, Nordestgaard Børge G, Lange Peter, Aalberg Vikjord Sigrid A, Breyer Marie-Kathrin, Kankaanranta Hannu, Lindberg Anne, Rönmark Eva, Vanfleteren Lowie E G W, Vestbo Jørgen, Wedzicha Jadwiga A, Melén Erik, Agustí Alvar, Faner Rosa, Afzal Shoaib
Аннотация
BACKGROUND: The extent to which airflow obstruction, a key feature of COPD, can be already present in early adulthood is unclear. We investigated the prevalence of airflow obstruction in young adults across European populations.
METHODS: We identified 48 612 individuals aged 20-40 years across eight population-based European cohorts in the Chronic Airway Diseases Early Stratification (CADSET) collaboration and applied two commonly used definitions of airflow obstruction: pre-bronchodilator forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) <0.70 and below the lower limit of normal (LLN). We explored how the prevalence of airflow obstruction according to both criteria was related to age, sex and smoking.
RESULTS: Airflow obstruction prevalence increased with increasing age from 2.3% in those aged 20-24.9 years to 6.3% in those aged 35-39.9 years according to FEV1/FVC <0.70, and from 7.3% to 8.3% according to FEV1/FVC <LLN. The corresponding increase in airflow obstruction prevalence was up to 8.8% in males versus 7.5% in females, and up to 9.0% in ever-smokers versus 6.9% in never-smokers. Difference in prevalence of airflow obstruction between FEV1/FVC <0.70 and <LLN was highest for females and ever-smokers. Active smoking ranged from 19% to 28% and ever-smoking from 37% to 51%. The prevalence of airflow obstruction increased with pack-years, plateauing at ∼5 pack-years.
CONCLUSION: Up to 8% of young adults across Europe have airflow obstruction; its cause and its role in prior, concurrent and future airway disease merit further investigation.
METHODS: We identified 48 612 individuals aged 20-40 years across eight population-based European cohorts in the Chronic Airway Diseases Early Stratification (CADSET) collaboration and applied two commonly used definitions of airflow obstruction: pre-bronchodilator forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) <0.70 and below the lower limit of normal (LLN). We explored how the prevalence of airflow obstruction according to both criteria was related to age, sex and smoking.
RESULTS: Airflow obstruction prevalence increased with increasing age from 2.3% in those aged 20-24.9 years to 6.3% in those aged 35-39.9 years according to FEV1/FVC <0.70, and from 7.3% to 8.3% according to FEV1/FVC <LLN. The corresponding increase in airflow obstruction prevalence was up to 8.8% in males versus 7.5% in females, and up to 9.0% in ever-smokers versus 6.9% in never-smokers. Difference in prevalence of airflow obstruction between FEV1/FVC <0.70 and <LLN was highest for females and ever-smokers. Active smoking ranged from 19% to 28% and ever-smoking from 37% to 51%. The prevalence of airflow obstruction increased with pack-years, plateauing at ∼5 pack-years.
CONCLUSION: Up to 8% of young adults across Europe have airflow obstruction; its cause and its role in prior, concurrent and future airway disease merit further investigation.